脈衝電磁場治療設備市場－全球產業規模、佔有率、趨勢、機會、預測：按功率、應用、最終用途、地區和競爭格局分類，2021-2031年

全球脈衝電磁場治療市場預計將從 2025 年的 5.5121 億美元成長到 2031 年的 8.0022 億美元，複合年成長率為 6.41%。

脈衝電磁場治療（PEMF）設備利用低頻電磁波刺激細胞代謝，提供了一種促進受損組織和骨骼修復的非侵入性方法。該市場成長的主要驅動力是慢性肌肉骨骼疾病的日益增加以及人們轉向非藥物療法以減少鴉片類藥物依賴。此外，老化社會整形外科疾病的增加也推動了旨在減輕發炎和促進骨骼癒合的此類療法的應用。

然而，先進系統的高成本和不一致的保險報銷政策往往阻礙了其廣泛應用，限制了許多消費者獲得治療的機會。儘管臨床上對有效的整形外科干預措施有著明確的需求，但這些經濟障礙仍然存在。國際骨質疏鬆症基金會（IOF）強調了復健技術的巨大需求，基金會估計，到2024年，全球每年將發生多達3700萬例脆性骨折，凸顯了開發可及治療方案的緊迫性。

市場促進因素

慢性疼痛和肌肉骨骼疾病盛行率的上升是全球脈衝電磁場（PEMF）療法市場的主要驅動力，顯著擴大了需要非藥物治療的患者群體。隨著人口老化和越來越多的人面臨退化性疾病，人們對有效且避免長期使用鴉片類藥物風險的疼痛管理替代方案的需求日益成長。美國疾病管制與預防中心（CDC）於2024年11月發布的NCHS數據簡報凸顯了這一問題的嚴重性，該簡報報告稱，2023年美國成年人中有24.3%患有慢性疼痛。此外，美國整形外科（ AGP）在其2024年肩肘關節登記年度報告中指出，與2022年相比，患者手術量增加了44%，顯示術後復健需求強勁。

同時，攜帶式和穿戴式式脈衝電磁場（PEMF）設備的科技進步正在加速從臨床環境向居家照護的轉變，並推動市場滲透。諸如延長電池續航時間、縮小裝置尺寸和簡化使用者介面等創新，使得骨骼生長刺激器和疼痛緩解穿戴裝置更加普及，滿足了以患者為中心的復健解決方案的需求。這種以患者為中心的設計趨勢正在推動行業領導者的財務成長。例如，Orthofix Medical Inc.在2024年11月發布的2024年第三季財報中顯示，其骨骼生長治療業務的淨銷售額年增9%，這充分體現了這些先進治療技術的商業性影響力。

市場挑戰

高昂的實施成本和不一致的保險報銷政策是全球脈衝電磁場（PEMF）療法市場成長的主要障礙。這些經濟障礙阻礙了非侵入式療法的普及，尤其是在對成本高度敏感的醫療保健領域。當先進治療技術的初始投資過高時，儘管其在治療整形外科疾病和控制慢性疼痛方面具有明顯的臨床益處，醫院和診所往往仍會猶豫是否將其納入標準復健通訊協定。

醫療器材製造商不斷上漲的營運成本進一步加劇了這種經濟壓力，不可避免地導致市場價格上漲。 2024年，《歐洲醫療技術》雜誌報告稱，由於監管要求日益嚴格，醫療設備製造商的認證維修成本增加了50%。為了在合規成本飆升的情況下維持利潤率，企業被迫維持高昂的採購價格，難以提供價格合理的產品。因此，市場擴張極其困難，因為保險公司和患者都不願意為這些骨骼癒合和疼痛管理解決方案支付巨額費用。

市場趨勢

獸醫和伴侶動物保健領域正崛起為關鍵成長點，其收入來源與人類整形外科相輔相成。製造商正積極將臨床級脈衝電磁場（PEMF）技術應用於馬匹和小動物，為骨關節炎和軟組織損傷提供非侵入性治療。這種策略多元化正在帶來可觀的財務效益。根據Zomedica公司於2025年11月發布的2025年第三季財報，包括脈衝床和Assisi產品在內的治療業務收入達到670萬美元，較去年同期成長3%。

同時，人工智慧 (AI) 和物聯網 (IoT) 連接的融合正將市場價值從獨立硬體轉向數據驅動的個人化治療生態系統。先進的設備利用行動應用程式和雲端連接即時監測患者的依從性，從而實現遠端通訊協定調整，改善臨床療效並增強對保險公司的課責。這種數位化變革正直接推動商業性應用，Orthofix Medical Inc. 於 2025 年 11 月發布的 2025 年第三季財報印證了這一點。該財報顯示，其骨骼生長治療業務的淨銷售額成長了 6%，達到 6,120 萬美元，證實了市場對數位化復健解決方案的強勁需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：脈衝電磁場治療設備的全球市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 輸出類型（低頻、高頻）
  • 透過應用（促進骨骼生長、緩解疼痛等）
  • 依最終用途（醫院、居家醫療機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美脈衝電磁場治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲脈衝電磁場治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區脈衝電磁場治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲脈衝電磁場治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲脈衝電磁場治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球脈衝電磁場治療設備市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Bedfont Scientific Ltd.
• Orthofix Medical Inc.
• IACER Srl
• OSKA, Inc.
• Medithera GmbH
• Guangzhou New Desai Biotechnology Co., Ltd.
• Nuage Health Devices Pvt. Ltd.
• Bemer USA, LLC
• Biomag Medical sro
• Aetna Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Pulse Electromagnetic Field Therapy Devices Market is projected to expand from USD 551.21 Million in 2025 to USD 800.22 Million by 2031, growing at a CAGR of 6.41%. PEMF devices utilize low-frequency electromagnetic waves to stimulate cellular metabolism, offering a non-invasive method to accelerate the repair of damaged tissues and bones. This market growth is primarily driven by the increasing prevalence of chronic musculoskeletal conditions and a shift toward non-pharmacological pain management to reduce opioid reliance. Additionally, the rising number of orthopedic ailments in the aging population further supports the adoption of these therapies for inflammation reduction and bone healing.

However, widespread adoption is frequently hindered by the high cost of advanced systems and inconsistent insurance reimbursement policies, which limit accessibility for many consumers. These financial barriers exist despite the clear clinical necessity for effective orthopedic interventions. The significant demand for rehabilitation technologies is underscored by the International Osteoporosis Foundation, which estimated in 2024 that up to 37 million fragility fractures occur globally each year, highlighting the urgent need for accessible therapeutic solutions.

Market Driver

The rising prevalence of chronic pain and musculoskeletal disorders serves as a primary driver for the Global Pulse Electromagnetic Field (PEMF) Therapy Devices Market, significantly expanding the patient base requiring non-pharmacological treatments. As aging populations increasingly face degenerative conditions, there is a growing demand for effective pain management alternatives that avoid the risks of long-term opioid use. Highlighting the magnitude of this issue, the Centers for Disease Control and Prevention's November 2024 'NCHS Data Brief' reported that 24.3% of U.S. adults experienced chronic pain in 2023. Furthermore, the American Academy of Orthopaedic Surgeons noted a 44% increase in submitted patient procedures in their October 2024 'Shoulder & Elbow Registry 2024 Annual Report' compared to 2022, indicating a robust pipeline of patients needing post-procedural rehabilitation.

Simultaneously, technological advancements in portable and wearable PEMF devices are accelerating market penetration by facilitating a shift from clinical settings to home-based care. Innovations in battery life, device miniaturization, and user-friendly interfaces have made bone growth stimulators and pain relief wearables more accessible, aligning with patient preferences for convenient recovery solutions. This trend toward patient-centric design is driving financial growth for industry leaders; for instance, Orthofix Medical Inc. reported in its November 2024 'Third Quarter 2024 Results' that net sales for its Bone Growth Therapies segment rose by 9% year-over-year, demonstrating the commercial impact of these advanced therapeutic technologies.

Market Challenge

High acquisition costs and inconsistent insurance reimbursement policies present a significant barrier to the growth of the Global Pulse Electromagnetic Field (PEMF) Therapy Devices Market. These financial obstacles restrict the accessibility of non-invasive systems for widespread consumer adoption, particularly in cost-sensitive healthcare sectors. When the upfront investment for advanced therapeutic technologies is prohibitive, hospitals and clinics are often reluctant to integrate them into standard rehabilitation protocols, despite the evident clinical benefits for treating orthopedic ailments and managing chronic pain.

This economic pressure is intensified by rising operational expenses for device manufacturers, which inevitably leads to higher market prices. In 2024, MedTech Europe reported that medical device manufacturers faced a 50% increase in certification maintenance costs due to stringent regulatory requirements. To protect profit margins amidst these escalating compliance costs, companies are compelled to maintain high acquisition fees, thereby sustaining the affordability gap. Consequently, the market struggles to expand as both insurers and patients are deterred by the substantial expenditures required for these bone healing and pain management solutions.

Market Trends

The expansion into veterinary medicine and companion animal healthcare is emerging as a critical growth area, establishing a revenue stream parallel to human orthopedics. Manufacturers are increasingly adapting clinical-grade PEMF technology for equine and small animal applications to provide non-invasive treatment for osteoarthritis and soft tissue injuries. This strategic diversification is yielding measurable financial results; according to Zomedica Corp.'s November 2025 'Third Quarter 2025 Financial Results', revenue for its Therapeutic Device segment, which includes PulseVet and Assisi products, reached $6.7 million, marking a 3% increase compared to the previous year.

Concurrently, the integration of Artificial Intelligence and IoT connectivity is transforming the market by shifting value from standalone hardware to personalized, data-driven therapeutic ecosystems. Advanced devices now utilize mobile apps and cloud connectivity to monitor patient compliance in real-time, enabling remote protocol adjustments that improve clinical outcomes and support payer justification. This digital evolution is directly driving commercial adoption; Orthofix Medical Inc. reported in its November 2025 'Third Quarter 2025 Financial Results' that net sales for its Bone Growth Therapies segment increased by 6% to $61.2 million, underscoring the strong market demand for digitally enabled rehabilitation solutions.

Key Market Players

• Bedfont Scientific Ltd.
• Orthofix Medical Inc.
• I.A.C.E.R. Srl
• OSKA, Inc.
• Medithera GmbH
• Guangzhou New Desai Biotechnology Co., Ltd.
• Nuage Health Devices Pvt. Ltd.
• Bemer USA, LLC
• Biomag Medical s.r.o.
• Aetna Inc.

Report Scope

In this report, the Global Pulse Electromagnetic Field Therapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pulse Electromagnetic Field Therapy Devices Market, By Power

• Low Frequency
• High Frequency

Pulse Electromagnetic Field Therapy Devices Market, By Application

• Bone Growth
• Pain Management
• Others

Pulse Electromagnetic Field Therapy Devices Market, By End Use

• Hospitals
• Home Care Settings
• Others

Pulse Electromagnetic Field Therapy Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pulse Electromagnetic Field Therapy Devices Market.

Available Customizations:

Global Pulse Electromagnetic Field Therapy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pulse Electromagnetic Field Therapy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Power (Low Frequency, High Frequency)
  • 5.2.2. By Application (Bone Growth, Pain Management, Others)
  • 5.2.3. By End Use (Hospitals, Home Care Settings, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Pulse Electromagnetic Field Therapy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Power
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Power
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Power
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Power
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Pulse Electromagnetic Field Therapy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Power
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Power
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Power
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Power
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Power
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Power
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Pulse Electromagnetic Field Therapy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Power
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Power
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Power
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Power
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Power
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Power
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Pulse Electromagnetic Field Therapy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Power
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Power
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Power
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Power
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Pulse Electromagnetic Field Therapy Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Power
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Power
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Power
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Pulse Electromagnetic Field Therapy Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Power
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pulse Electromagnetic Field Therapy Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bedfont Scientific Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Orthofix Medical Inc.
• 15.3. I.A.C.E.R. Srl
• 15.4. OSKA, Inc.
• 15.5. Medithera GmbH
• 15.6. Guangzhou New Desai Biotechnology Co., Ltd.
• 15.7. Nuage Health Devices Pvt. Ltd.
• 15.8. Bemer USA, LLC
• 15.9. Biomag Medical s.r.o.
• 15.10. Aetna Inc.

16. Strategic Recommendations

17. About Us & Disclaimer